Malin Corporation | MLC - Beneficio Operativo

Precio De Mercado
7.60
Cambio Diario
-0.40 -5.00%
Mensual
-8.43%
Anual
-10.59%
Q2 Expectativa
7.76




Beneficio Operativo Cambio Fecha
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
ALKERMES USD -48.28M 37.33M 2026-03
Avita Medical AUD -10.41M 742K 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Eurofins Scientific SE EUR 391.3M 139.6M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Lonza CHF 673M 243M 2025-06
Malin Corporation EUR -1.1M 400K 2024-12
Moderna USD -1.39B 531M 2026-03
Organon & Co USD 217M 171M 2025-12
Ovoca Bio EUR -1.16M 4.48M 2025-06
Revvity USD 82.77M 63.06M 2026-03
Tectonic Therapeutic USD -21.52M 374K 2025-12
Viatris USD -20.2M 137.3M 2026-03
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12